MRK vs BAX
By Alex · Tickerpine
Merck & Co., Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BAX |
|---|---|---|
| Price | $147.76 | $25.81 |
| Market cap | $364.26B | $13.35B |
| P/E ratio | 149.3 | — |
| ROE | 5.06% | -9.04% |
| Profit margin | 3.64% | -6.23% |
| Revenue growth | 4.70% | 5.00% |
| Dividend yield | 2.30% | 0.16% |
| Beta | 0.12 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BAX in plain English
- MRK is the bigger company — about 27.3× the market cap of BAX.
- MRK earns a higher return on equity (5% vs -9%).
- BAX is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.16%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.